Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 12/16/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Edward J. Septimus

Wrong Dr. Edward J. Septimus?

Clinical Services Group

Local Address: Houston, Texas, United States
HCA Inc.
One Park Plaza
Nashville , Tennessee 37203
United States

Company Description: HCA owns and operates approximately 179 hospitals and approximately 104 freestanding surgery centers in 21 states, England and Switzerland. We are dedicated to...   more

Employment History

Board Memberships and Affiliations


  • M.D.
  • medical degree
    Baylor College of Medicine
  • MD , Infectious Diseases
  • MD HCA
128 Total References
Web References
So when the results were final ..., 16 Dec 2014 [cached]
So when the results were final last year, HCA began implementing baths with CHG cloths in ICUs at each of its 165 hospitals across the country, says Edward Septimus, M.D., HCA's medical director for infection prevention and epidemiology. While the new practice means a significant increase in products that must be provided by supply chain professionals, the results have been powerful in terms of keeping patients healthy.
In addition to using CHG cloths to reduce MRSA infections, hospitals also have found success recently by using alcohol caps that fit over medicine ports. When the port is not in use, alcohol bathes the connector, a process that has been able to reduce infections. The use of these alcohol caps is the newest product-based approach to preventing infections, having been in practice only during the past year or so, Septimus says.
"It's important to note that alcohol caps are considered a special approach and not a routine standard of care. But for hospitals to continue to see decreased bloodstream infections, their use may be an effective strategy," he says.
"So now these kits have everything necessary to help healthcare professionals make sure they complete each step," Septimus says. "The infection rate is higher if you use a different type of skin preparation or make other slight changes, so when our supply chain professionals package everything together, that helps us do it right every time."
For some infections, specific techniques in providing care are more important for preventing infections than the products used. For instance, in certain populations, some hospitals have been using silver bladder catheters in an effort to reduce urinary tract infections, Septimus says.
However, a more definitive study published in 2012 showed that silver catheters did not reduce the occurrence of symptomatic urinary tract infections. Instead, "it's more important to focus on techniques such as hand-washing, inserting catheters only when needed and taking them out when they are not needed," Septimus says.
For instance, the landmark MRSA study couldn't have been completed "without the supply chain having what we needed available to take care of every patient," Septimus says.
However, the products that are most effective in keeping patients healthy aren't always the most cost-effective ones. And implementing new products or changing orders to help fight infections can be a lengthy, difficult process. For that reason, it's vital that supply chain professionals understand how their purchasing decisions may impact the lives of patients.
"It's important for supply chain professionals to understand how they fit in as part of the team approach to healthcare," Septimus says.
Septimus says financial decision-makers should be involved from the beginning of a project to reduce hospital infections. If not, a product may go through the stages of observation and recommendation, only to be refused by a budget officer because it wasn't included in the facility's budget.
By taking a long-term view, hospital personnel can focus on the savings of infection prevention purchases, rather than the immediate costs. For instance, patients who leave the hospital with an infection may become disabled or require further hospitalization, which will result in further cost to society, if not the hospital itself.
"If we prevent a certain number of infections, not only are we saving lives, but we're saving money as well," Septimus says.
APIC |, 19 Mar 2012 [cached]
"Antimicrobial stewardship: A collaborative partnership between infection preventionists and healthcare epidemiologists," by Julia Moody, Sara E. Cosgrove, Russell Olmsted, Edward Septimus, Kathy Aureden, Shannon Oriola, Gita Wasan Patel, and Kavita Trivedi, appears in the American Journal of Infection Control, Volume 40, Issue 2 (March 2012), and Infection Control and Hospital Epidemiology, Volume 33, Issue 4 (April 2012).
Edward Septimus, MD, FACP, FIDSA, FSHEA HCA, Inc., Nashville, Tenn., SHEA advisor
MicroResistance.Org, 8 April 2014 [cached]
Past President: Edward J. ..., 18 Jan 2015 [cached]
Past President: Edward J. Septimus, M.D., F.I.D.S.A, F.A.C.P, F.S.H.E.A.
Dr. Ed Septimus is originally from New York City. He received his medical degree from Baylor College of Medicine in Houston in 1972. Dr. Septimus went on to complete his postgraduate training in internal medicine and infectious diseases at Baylor College of Medicine in Houston. For the next 30 years Dr. Septimus practiced infectious diseases where he formed a 3 person specialty group in infectious diseases in Houston. He was also medical director of infectious diseases and employee health at Memorial Hermann Healthcare System until November 2005. Dr. Septimus then moved to Montana to become Medical Director of Patient Safety and Infection Control at Billings Clinic. His current position is Medical Director Infection Prevention and Epidemiology Clinical Services Group HCA Healthcare System. He has just finished a 3 year term on the Board of Directors of the Infectious Diseases Society of America (IDSA), and is on the IDSA Quality Improvement Task Force, and IDSA Antimicrobial Resistance Work Group. He has also served on the IDSA Clinical Affairs Committee, IDSA Program Committee, and IDSA State and Regional Board including chair for two years. He was the first recipient of the IDSA Annual Clinician Award. He served on the Houston Medical Advisory Steering Committee on Terrorism and the MRSA Work Group for the Texas Department of Health and recently was appointed to the Infectious Diseases Workgroup for the Texas Department of Health and the FDA Anti-Infective Drug Advisory Group. He holds a faculty position as Clinical Professor at Texas A&M Medical School and Affiliate Professor, Distinguished Senior Fellow, School of Public Health, George Mason University.
He also serves on the Leading Practice Advisory Panel for VHA, the Board International Society for Antimicrobial Resistance, the SHEA/IDSA Antimicrobial Stewardship Task Force and the SHEA HCW Influenza Vaccine Working Group. Current interests include patient safety, infection prevention, public health, sepsis, medical informatics, clinical integration, and human factors engineering. Dr. Septimus has lectured nationally and internationally on surviving sepsis, reduction of healthcare-associated infections, antimicrobial stewardship, MRSA, the economic case for quality, and employee health.
Advisory Board | ICNet Asia Pacific, 24 May 2014 [cached]
Ed Septimus, MD - Texas A&M Health Science Center, Houston
Ed Septimus, MD, is Professor of Internal Medicine at Texas A&M Health Science Center in Houston. Dr. Septimus received his MD from Baylor College of Medicine in Houston in 1972, where he also completed postgraduate training in internal medicine and infectious diseases. Previously, he was Medical Director of Infectious Diseases and Employee Health at Memorial Hermann Healthcare System in Houston. He completed a three-year term on the board of the Infectious Diseases Society of America (IDSA) in 2009, and is on the IDSA Antimicrobial Resistance Work Group, the IDSA/Society for Healthcare Epidemiology of America (SHEA) Antimicrobial Stewardship Work Group and SHEA's Public Policy and Governmental Affairs Committee. Dr. Septimus was the first recipient of the IDSA Annual Clinician Award and was awarded the John S. Dunn Sr. Outstanding Teacher Award in 2010 and 2011. He is on the Food and Drug Administration's Anti-Infective Drug Advisory Group and co-chair of the National Quality Forum's Infectious Disease Steering Committee. He is a clinical professor at Texas A&M Medical School and is professor and distinguished senior fellow at the George Mason University School of Public Health. He is on the board of the International Society for Antimicrobial Resistance and is the chair for the IHI Antibiotic Stewardship Project. He is president of the Texas Infectious Diseases Society and has published more than 90 articles and chapters.
Other People with the name "Septimus":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.